MoneyWorks4Me

A decrease in the sales to Rs. 332.86 millions was observed for the quarter ended June 2024. The sales stood at Rs. 419.47 millions during the similar quarter previous year.The Net Loss for the quarter ended June 2024 is Rs. -7.23 millions as compared to Net Profit of Rs. 63.50 millions of corresponding quarter ended June 2023A decline of 17.17 millions was observed in the OP in the quarter ended June 2024 from 81.63 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 332.86 419.47 -20.65 332.86 419.47 -20.65 1524.66 1153.50 32.18
Other Income 5.05 18.69 -72.98 5.05 18.69 -72.98 35.22 32.73 7.61
PBIDT 17.17 81.63 -78.97 17.17 81.63 -78.97 146.34 189.90 -22.94
Interest 6.51 6.01 8.32 6.51 6.01 8.32 22.90 20.38 12.37
PBDT 7.21 75.62 -90.47 7.21 75.62 -90.47 123.44 169.52 -27.18
Depreciation 14.44 12.12 19.14 14.44 12.12 19.14 49.95 53.34 -6.36
PBT -7.23 63.50 -111.39 -7.23 63.50 -111.39 73.49 116.18 -36.74
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.78 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -7.23 63.50 -111.39 -7.23 63.50 -111.39 73.49 113.40 -35.19
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 5.16 19.46 -73.49 5.16 19.46 -73.49 9.60 16.46 -41.70
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..